LSP-SCN8A

N/A

Report date: 2025/01/26 18:25:11
NME

Base Information

Drug NameLSP-SCN8A
Drug Alias NameSCN8A splicing targeted SMOs (LifeSplice Pharma)LSP-SCN8A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionSodium channel protein type VIII alpha subunit modulators
TargetsSodium channel protein type VIII alpha subunit
Therapy Area/IndicationsEpilepsies, Myoclonic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLifeSplice Pharma LLC
China Registration ClassN/A

Develop Information

Active CompaniesLifeSplice Pharma LLC
Inactive CompaniesN/A
Active IndicationsEpilepsies, Myoclonic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A